IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

REGIUS PHARMA LLP

LLPIN : ACK-2483|ROC: RoC-HyderabadActive
Last Updated On : 02-12-2024
LLPINACK-2483
LLP NameREGIUS PHARMA LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Hyderabad
Date of Incorporation07-11-2024
Registered AddressH.No.1-98V103,Flat No.103,Plot No.17 and 18,Vishnu Avenues, Krithika Layout, Madhapur, NA Hyderabad Hyderabad Telangana India 500081
Email IDkiran@cornileus.com
Total Obligation of Contribution2,01,890
Main division of business activity to be carried out in India21
Description of main divisionMANUFACTURING
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
00669908KIRAN KUMAR NALAMOTHU07-11-2024
07964895VIJAYALAKSHMI NALAMOTHU07-11-2024
REGIUS PHARMA LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Hyderabad, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 07-11-2024 and last updated on 02-12-2024. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, REGIUS PHARMA LLP has a total contribution of INR 2,01,890. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is H.No.1-98V103,Flat No.103,Plot No.17 and 18,Vishnu Avenues, Krithika Layout, Madhapur, NA Hyderabad Hyderabad Telangana India 500081. Correspondence or inquiries may be sent to the official email address, kiran@cornileus.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.